Apidra Now on Pharmacy Shelves
On February 28, 2006, sanofi-aventis announced that its fast-acting Apidra (insulin glulisine [rDNA origin] injection) is now available by prescription in the United States. Apidra was granted FDA approval in April 2004.
Sanofi-aventis says that Apidra should be used in regimens that include a longer-acting insulin or basal insulin analogue such as Lantus.
Sanofi-aventis also announced that Apidra cartridges are now available for use with the OptiClik insulin pen, which is also currently approved for use with Lantus.
In a sanofi-aventis press release, Richard M. Bergenstal, MD, executive director of the International Diabetes Center at Park Nicollet, Minneapolis, Minnesota, says, “Controlling mealtime blood sugar spikes is a crucial part of managing diabetes. Apidra is a welcome addition to the armamentarium of all healthcare professionals who treat adults with diabetes.”
Source: sanofi-aventisClick Here To View Or Post Comments